Last update 23 Jan 2025

Waterstone Hanxbio Pty Ltd

Private Company

Overview

Related

1
Drugs associated with Waterstone Hanxbio Pty Ltd
HX-009
Target
PD-1 x SIRPα
Mechanism
PD-1 inhibitors [+1]
Active Org.
Hangzhou Hansi Biological Pharmaceutical Co., Ltd.
Originator Org.
Wuhan Hanxiong Biotech,inc.
Active Indication
Biliary Tract Neoplasms [+5]
Inactive Indication
Liver Cancer [+1]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Waterstone Hanxbio Pty Ltd
NCT04886271
/ Unknown statusPhase 2
A Multicenter Phase II Clinical Study of Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors
NCT04097769
/ CompletedPhase 1
A Phase I, First-in-Human Study Evaluating the Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies
100 Clinical Results associated with Waterstone Hanxbio Pty Ltd
Login to view more data
0 Patents (Medical) associated with Waterstone Hanxbio Pty Ltd
Login to view more data
100 Deals associated with Waterstone Hanxbio Pty Ltd
Login to view more data
100 Translational Medicine associated with Waterstone Hanxbio Pty Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
HX-009
 ( PD-1 x SIRPα )		Advanced Malignant Solid Neoplasm
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free